ストックスクリーナーアプリを入手
7.44
11.88%
0.79
アフターアワーズ：
7.44
前日終値:
$6.65
開ける：
$6.6
24時間の取引高:
252.02K
Relative Volume:
0.60
時価総額：
$370.80M
収益：
$13.55M
当期純損益:
$-25.32M
株価収益率:
-13.73
EPS:
-0.542
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.20%
1か月 パフォーマンス:
+38.03%
6か月 パフォーマンス:
+55.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$6.50
$7.50
1週間の範囲:
$6.255
$7.7904
52週間の値動き範囲:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Compare CV vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
7.44 | 370.80M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 開始されました | Roth Capital | Buy |
| 2025-07-28 | 開始されました | The Benchmark Company | Speculative Buy |
Capsovision Inc (CV) 最新ニュース
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
Major CapsoVision (CV) holder Shen Ching Hang reports large direct and indirect stake - Stock Titan
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2% - MarketBeat
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline By Investing.com - Investing.com Australia
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline - au.investing.com
CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark - MarketBeat
CapsoVision 2025 Financial Performance Review - AlphaStreet
CapsoVision revenue up 13% to USD 3.9M in Q4 2025 - medicalbuyer.co.in
CapsoVision’s CapsoCam: 360° Panoramic AI-Powered Capsule Endoscopy Solution Expanding Global GI Diagnostics Market 2324323344 - minichart.com.sg
Large CapsoVision (CV) holder discloses direct and trust share stakes - Stock Titan
CapsoVision Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips - Investing.com Australia
CapsoVision Q4 Earnings Call Highlights - MarketBeat
CapsoVision Inc reports results for the quarter ended September 30Earnings Summary - TradingView
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
CV: AI-powered capsule endoscopy drives growth and innovation in noninvasive GI screening - TradingView
CapsoVision 10-K: Revenue $13.6M, EPS $(1.03) — Annual Results - TradingView
CapsoVision (NASDAQ: CV) flags going concern while advancing AI colon capsule - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
CapsoVision Faces Deadline to Turn Capital Into Profit Before Runway Collapses - Bitget
CapsoVision (NASDAQ: CV) grows 2025 revenue 15% as net loss widens - Stock Titan
CapsoVision, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
CapsoVision Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening - MarketBeat
CapsoVision price target raised to $11 from $7 at Roth Capital - tipranks.com
CapsoVision (CV) director receives 4,045 RSU equity award - Stock Titan
CapsoVision (CV) awards 4,045 RSUs to board director - Stock Titan
CapsoVision (CV) director receives 4,045 RSU grant as board compensation - Stock Titan
CapsoVision (CV) director receives 4,045 RSUs vesting through 2026 - Stock Titan
CapsoVision (CV) awards 4,045 restricted stock units to director - stocktitan.net
[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan
CV: AI-powered capsule endoscopy targets multi-cancer detection with global expansion and strong funding - TradingView
CV: CapsoVision advances AI-powered capsule endoscopy with strong pipeline and global expansion - TradingView
CapsoVision’s Strategic Moves Spike Stock as Market Anticipates Growth - timothysykes.com
CapsoVision Surges 13% on Closing $14M Private Placement - StocksToTrade
CapsoVision closes $14 million private placement financing By Investing.com - Investing.com Australia
CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | H6U | US1409351079 - marketscreener.com
CapsoVision Closes $14 Million Private Placement and Reports Preliminary 2025 Financial Results - minichart.com.sg
CapsoVision Raises Capital and Refocuses Colon Capsule Strategy - TipRanks
CapsoVision closes $14 million private placement financing - Investing.com
CapsoVision Raises ~$14 Million in Private Placement, Selling 2.87M Shares at $4.883 - tradingview.com
CapsoVision (NASDAQ: CV) secures $14M and pivots colon capsule strategy - stocktitan.net
CapsoVision Announces $14 Million Private Placement Financing - GlobeNewswire
Fresh $14M gives CapsoVision cash to fund AI and capsule scope push - Stock Titan
CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | CV | US1409351079 - marketscreener.com
What Is CapsoVision's Roadmap For Growth And Innovation In 2026? - RTTNews
CapsoVision Inc Trading Resumes - MSN
CapsoVision, Inc. Announces Amendment to Sample Purchase Agreement with Canon Inc. for CMOS Image Sensor Development 5 - minichart.com.sg
CapsoVision increases development fee in amended agreement with Canon By Investing.com - Investing.com South Africa
CapsoVision increases development fee in amended agreement with Canon - Investing.com
CapsoVision Amends Canon Agreement for Upgraded Image Sensors - TipRanks
Capsovision Inc (CV) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
大文字化:
|
ボリューム (24 時間):